Cryptic Nocardia nova brain abscess postradiation treatment and neurosurgery in a patient with small cell lung cancer: A case report and review of the literature  by Abel, Stephen et al.
Advances in Radiation Oncology (2016) 1, 290-293www.advancesradonc.orgTeaching CaseCryptic Nocardia nova brain abscess
postradiation treatment and neurosurgery in a
patient with small cell lung cancer: A case
report and review of the literature
Stephen Abel BS a, Shaakir Hasan DO b,*, Brandon Kujawski MD c,
Aditya Talwar MD c, James Betler DO b, Rodney Wegner MD b,
Athanasios Colonias MD b, Khaled Aziz MD PhD c
a Lake Erie College of Osteopathic Medicine, Bradenton, Florida
b Department of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania
c Department of Neurosurgery, Allegheny Health Network, Pittsburgh, PennsylvaniaReceived 23 July 2016; accepted 3 August 2016Introduction
In 2016, a projected 30,000 to 40,000 Americans will
be diagnosed with small cell lung cancer (SCLC),1 and
approximately 10% to 20% of them will have brain
metastasis at time of diagnosis.2 The intrinsic radiosen-
sitivity and propensity of SCLC to metastasize intracra-
nially provides the rationale for whole brain radiation
therapy (WBRT), either prophylactically or therapeuti-
cally. Given the aggressive nature of SCLC, intracranial
recurrence is not uncommon.3 Recurrent intracranial
metastasis is typically treated with focal or whole brain
reirradiation; however, given the added neurotoxicity
risks of reirradiation, other options such as surgery or
systemic therapy may be offered.
Toxicities of systemic therapy, such as myelosup-
pression, can complicate the management of SCLC.
Despite the expanded differential diagnoses that often
accompany immunocompromised patients, clinicians may
fail to consider all possibilities when managing this patientConﬂicts of interest: None.
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mised patient with SCLC whose apparent metastatic brain
recurrence was in actuality an uncommon infectious agent.Case report
A67-year-oldmalewith a 30 pack-year smoking history
presented with new-onset grand mal seizure. A brain
magnetic resonance imaging (MRI) scan revealed 4 intra-
cranial lesions; the largest a 1.5 cm  1.8 cm ring
enhancing lesion in the right temporal lobe with signiﬁcant
edema (Fig 1). The patient was treated with dexametha-
sone, levetiracetam, and a navigation-guided craniotomy
with temporal lobe resection. A soft, tan-brown, 1.7 cm
mass was visualized under the dura and totally resected
without violating the surrounding vasculature via micro-
dissector under high magniﬁcation. Pathology of the
resected brain mass demonstrated metastatic, poorly
differentiated neuroendocrine carcinoma with immuno-
histochemical positivity for PANCK, TTF1, CK7, chro-
mogranin, synaptophysin, and CD56 (Fig 2). A positron
emission tomography-computed tomography scan
revealed a 2 cm mass in the right middle lobe yielding a
diagnosis of extensive-stage SCLC, T1N1M1.of the American Society for Radiation Oncology. This is an open access
by-nc-nd/4.0/).
Figure 1 T2-weighted axial brain magnetic resonance imag-
ing scan showing a hypointense lesion with surrounding edema
in right temporal lobe.
Figure 3 Diffusion weighted axial brain magnetic resonance
imaging scan showing restricted diffusion in the left frontopar-
ietal region.
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10 fractions was delivered followed by 4 cycles of car-
boplatin and etoposide, with 4 mg dexamethasone every 6
hours throughout treatment. A progressive and debili-
tating dizziness developed after the ﬁrst round of
chemotherapy and was exacerbated by attempted steroidal
taper. Two days after completing round 3 (of 4) of
chemotherapy and 52 days after completion of WBRT,
the patient was hospitalized because of iatrogenic exog-
enous adrenal insufﬁciency. During this admission, an
MRI scan of the brain showed a ring enhancing 0.6 cm
left frontal-parietal lesion concerning for new metastasis.
To treat the presumed recurrence, palliative external
beam radiation was limited to the left supratentorial and
parietal areas of the brain at a dose of 25 Gy over 10
fractions, followed by the fourth and ﬁnal round ofFigure 2 Dense sheets of malignant cells with scant cyto-
plasm, prominent nuclei, and absent nucleoli consistent with
small cell carcinoma.chemotherapy. One week later, the patient developed a
right-sided facial droop and expressive aphasia. Non-
contrast CT of the head demonstrated a 2.3 cm  2.3 cm
left frontal mass within the previously irradiated ﬁeld,
causing a midline shift. An MRI scan with and without
contrast conﬁrmed a ring-enhancing mass with restricted
diffusion and signiﬁcant edema (Figs 3 and 4).Figure 4 T2-weighted axial brain magnetic resonance imag-
ing scan showing hypointense rim with hyperintense heteroge-
nous core in the left frontoparietal region.
Figure 5 Gram-positive rods contained within organized pu-
rulent matter consistent with abscess.
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toms, immunocompromised state, and presence of
restricted diffusion on MRI scan, metastasis was consid-
ered less likely in favor of a brain abscess. Subsequently,
Burr hole craniotomy with aspiration of the lesion pro-
duced a purulent specimen, of which Gram stain showed
“ﬁne ﬁlamentous beaded bending” Gram-positive rods,
and ultimately grew Nocardia nova (Fig 5).
The patient was treated with trimethoprim-
sulfamethoxazole and intravenous meropenem for 6
weeks. Over the next 3 months, the patient required 2
additional craniotomies with aspiration after repeat brain
MRI scans showed abscess reaccumulation in the previous
location. At last follow-up, the patient remains on
trimethoprim-sulfamethoxazole and meropenem, with min-
imal improvement of his right-sidedweakness and dizziness.
Discussion
A cerebral abscess in the setting of brain metastasis is
an unexpected phenomenon. Ring-enhancing lesions in a
SCLC patient with intracranial metastasis likely repre-
sents recurrence. However, a broad differential is imper-
ative for appropriate management. Given that this patient
was treated with WBRT to 30 Gy, followed by 25 Gy to
the left cerebral hemisphere within 2 months for aTable 1 Common intra-axial contrast enhancing lesions on neuro
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Lymphoma Thick, irregular Ispresumed recurrence, the likelihood of local recurrence
should be carefully weighed against alternative diagnoses.
The differential for contrast-enhancing intracranial lesions
(Table 1) is comprehensive; but in the context of clinical
history and examination, laboratory data, and discerning
neuroimaging features, the list can be modiﬁed appro-
priately. New metastasis, recurrence, lymphoma, abscess,
and radiation necrosis were all possible in this case, and
given the recent radiation and concern for radionecrosis,
surgery was a reasonable therapeutic option that ulti-
mately diagnosed an N. novo brain abscess. Although
radiation necrosis was strongly considered, the clinical
picture of an immunosuppressed patient, in conjunction
with characteristic MRI ﬁndings (circular, continuous,
thin-walled border without irregularities) were more
suggestive of an abscess. Furthermore, the interval of time
from last radiation treatment was shorter than expected if
radiation necrosis was the etiology, although radiographic
pseudoprogression certainly would fall within the elapsed
timeframe.6
Nocardiosis of the central nervous system is a rare
cause of cerebral abscesses, accounting for only approx-
imately 2% or 30 to 50 annual cases.7 The subject in this
case carried several risk factors for Nocardia brain ab-
scess, including long-term corticosteroid therapy,
chemotherapy-induced leukopenia, and previous brain
pathology. Clinical diagnosis is difﬁcult because the
presentation mimics other brain pathology and classic
signs and symptoms of infection (ie, fever) are often
hidden in immunocompromised patients. Retrospective
reviews indicate that the median time to diagnosis of
intracranial Nocardia is 30 days.8 Decreasing the time to
diagnosis is paramount because the mortality associated
with Nocardia-related abscesses is greater than 3 times
that from other bacterial etiologies.9 If the initial appear-
ance of the 0.6 cm left frontoparietal lesion is assumed to
be the start of the Nocardia abscess in this case, the time
to diagnosis was 48 days.
Identiﬁcation of Nocardia-related intracranial abscess
is particularly challenging in the presence of prior brain
tumors or radiation therapy, given similarities inimaging4,5
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magnetic resonance techniques such as spectroscopy,
noninvasive measures of detection may be on the hori-
zon.10 However, biopsy or aspiration remains the most
reliable way to differentiate one diagnosis from the next.
The morbidity of such procedures in already sick patients
can present a dilemma for clinicians. Nonetheless, in
select cases, when a brain lesion is anatomically acces-
sible and the clinical picture is ambiguous or clouded by
prior treatment and risk factors for infection, a biopsy
should be strongly considered. This case exempliﬁes how
the application and careful navigation through a broad
differential may uncover a rare disease entity.References
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